These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 7226734)

  • 21. Uricosuric action of cholecystographic agents. A possible factor in nephrotoxicity.
    Mudge GH
    N Engl J Med; 1971 Apr; 284(17):929-33. PubMed ID: 5551801
    [No Abstract]   [Full Text] [Related]  

  • 22. Single-visit oral cholecystography.
    Burhenne HJ; Obata WG
    N Engl J Med; 1975 Mar; 292(12):627-8. PubMed ID: 1113743
    [No Abstract]   [Full Text] [Related]  

  • 23. The effect of fasting on gallbladder opacification during oral cholecystography: a controlled study in normal volunteers.
    Loeb PM; Berk RN; Janes JO; Perkin L; Moore J
    Radiology; 1978 Feb; 126(2):395-401. PubMed ID: 341220
    [TBL] [Abstract][Full Text] [Related]  

  • 24. How to do an oral cholecystogram.
    Lorman JG; Rosenbaum HD
    Semin Roentgenol; 1976 Jul; 11(3):165-70. PubMed ID: 941032
    [No Abstract]   [Full Text] [Related]  

  • 25. A new contrast agent for oral cholecystography: iopronic acid (Oravue).
    Pizzolato NF; Arcomano JP; Baum AE
    AJR Am J Roentgenol; 1978 May; 130(5):845-7. PubMed ID: 417581
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Human tolerance of iopanoic acid (Telepaque).
    Hankins WD
    Radiology; 1971 Nov; 101(2):434. PubMed ID: 5114784
    [No Abstract]   [Full Text] [Related]  

  • 27. [Clinical experience with "gallpaque", an oral contrast medium for cholecystography].
    Mihara O; Matsuo T; Kido C
    Rinsho Hoshasen; 1974 Jul; 19(7):571-5. PubMed ID: 4471775
    [No Abstract]   [Full Text] [Related]  

  • 28. [Theoretical considerations for improving oral cholegraphy (author's transl)].
    De Reus HD
    Rontgenblatter; 1975 Aug; 28(8):362-72. PubMed ID: 1215770
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Results obtained in comparative radiographie, clinical and clinical-chemical studies in iocetamic acid (DRC 1201) and iopanoic acid.
    Hekster RE
    Radiol Clin Biol; 1968; 37(6):338-52. PubMed ID: 5714064
    [No Abstract]   [Full Text] [Related]  

  • 30. The combined use of oral cholecystopaque media and iodipamide.
    Goergen T; Goldberger LE; Berk RN
    Radiology; 1974 Jun; 111(3):543-8. PubMed ID: 4828985
    [No Abstract]   [Full Text] [Related]  

  • 31. [Contribution to protracted peroral cholecystography].
    Bruna J
    Cesk Radiol; 1967 Jul; 21(4):245-9. PubMed ID: 6055873
    [No Abstract]   [Full Text] [Related]  

  • 32. [Kidney repercussions of bile duct contrast media administration].
    Billis A; Dimopoulos C; Giamarellou H; Zoubouli I; Papadimitriou A; Sagiorgis G; Kaniouras N; Scouteris M; Daikos G
    J Urol Nephrol (Paris); 1973 Dec; 79(12 Pt 2):447-50. PubMed ID: 4804417
    [No Abstract]   [Full Text] [Related]  

  • 33. [Cholecysto-cholangiography with special reference to oral and intravenous methods].
    Shinoara S; Akazaki I
    Saishin Igaku; 1970 Nov; 25(11):2267-74. PubMed ID: 4920650
    [No Abstract]   [Full Text] [Related]  

  • 34. The 4-day cholecystographic test.
    Salzman E
    Semin Roentgenol; 1976 Jul; 11(4):171-3. PubMed ID: 941043
    [No Abstract]   [Full Text] [Related]  

  • 35. An evaluation of oral cholecystography.
    Rosenbaum HD
    JAMA; 1974 Jul; 229(1):76-9. PubMed ID: 4406744
    [No Abstract]   [Full Text] [Related]  

  • 36. [Pharmacology of oral cholecystography].
    Gaón D
    Acta Gastroenterol Latinoam; 1980; 10(3):231-41. PubMed ID: 7013405
    [No Abstract]   [Full Text] [Related]  

  • 37. Residual contrast medium in the intestines and side effects during cholecystography. A comparison between some contrast media in current use and a new medium.
    Eriksson S; Saltzman GF
    Acta Radiol Diagn (Stockh); 1970 Jan; 10(1):69-75. PubMed ID: 5447107
    [No Abstract]   [Full Text] [Related]  

  • 38. [Clinico-radiological study of 3 radiopaque substances used in oral cholecystography].
    Ipinza I
    Rev Med Chil; 1982 Aug; 110(8):761-5. PubMed ID: 7156610
    [No Abstract]   [Full Text] [Related]  

  • 39. The consecutive dose phenomenon in oral cholecystography.
    Berk RN
    Am J Roentgenol Radium Ther Nucl Med; 1970 Oct; 110(2):230-4. PubMed ID: 5472655
    [No Abstract]   [Full Text] [Related]  

  • 40. Gallbladder density and iodine concentration in humans during oral cholecystography. A comparison of iopanoic acid and iopronic acid.
    Thompson WM; Meyers WC; Shaw M; Bates M; Johnson GA; Hedlund LW
    Invest Radiol; 1982; 17(6):621-8. PubMed ID: 6759456
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.